2022-501477-40-00招募中1 期
A study to learn the effects of ripretinib (study drug) on how midazolam behaves in the body of people with advanced gastrointestinal stromal tumor
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 22
- 试验地点
- 6
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical trial information
Scientific
Deciphera Pharmaceuticals Inc.
研究点 (6)
Loading locations...
相似试验
招募中
1 期
A study to learn the effects of ripretinib (study drug) on how midazolam behaves in the body of people with advanced gastrointestinal stromal tumorAdvanced Gastrointestinal Stromal TumorMedDRA version: 21.1Level: PTClassification code: 10051066Term: Gastrointestinal stromal tumour Class: 100000004864CTIS2022-501477-40-00Deciphera Pharmaceuticals Inc.22
招募中
3 期
52 weeks double-blind, double-dummy, randomized placebo-controlled trial to evaluate safety, efficacy and tolerability of remibrutinib in comparison to placebo with omalizumab as active control in adult patients with CSU and inadequate response to H1-antihistamine and an open-label 52-week optional extension to assess long-term efficacy, safety and tolerability of remibrutinib 25 mg b.i.d.2022-502161-19-00Novartis Pharma AG214
已完成
2 期
A Randomized Phase 2 Study of Erdafitinib Versus Investigator Choice of Intravesical
Chemotherapy in Subjects Who Received Bacillus Calmette-Guérin (BCG) and Recurred
With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) and FGFR Mutations or
Fusions2023-510306-40-00Janssen Cilag International6
招募中
3 期
A Study of LY3437943 in Participants with Type 2 Diabetes Mellitus who have Obesity or Overweight (TRIUMPH-2)ObesityType 2 Diabetes2023-503658-11-00Eli Lilly & Co.235
招募中
3 期
Comparison between rituximab plus zanubrutinib versus rituximab monotherapy in untreated splenic marginal zone lymphoma patients2023-503755-10-00Association International Extranodal Lymphoma Study Group90